Bio & Health
·
Industrial Microbial Terpenoid Production
Microbial Chemical Production
At what fraction of the 0.667 mol/mol stoichiometric ceiling does overlay-free limonene production in E. coli stall as specific productivity falls by half?
THE QUESTION
For a heterologous mevalonate-to-limonene pathway in E. coli, which promoter and enzyme-homolog combination exceeds 5 g/L in the AQUEOUS phase — against the 3.6 g/L aqueous record, 7.3 g/L in organic overlay — and is the ceiling pathway flux or limonene cytotoxicity?
WORK ORDER
Carbon-closed yield and mevalonate intermediate pools at the overlay-free limonene stall point
BACKGROUND
What this Apodex Lab is
Producing renewable terpene chemicals such as limonene by fermenting industrial sugars offers an alternative to petrochemical synthesis, but yields in water-based culture stall at modest titres. Fermentations frequently add an immiscible organic solvent overlay to strip limonene continuously as it forms, reaching 7.3 g/L compared with an aqueous-phase record of 3.6 g/L. However, operating a two-phase extraction overlay in production bioreactors adds substantial operational complexity. Determining whether an engineered bacterium can achieve an overlay-free specification above 5 g/L requires establishing whether specific productivity ceases because metabolic pathway capacity is exhausted or because the accumulated product poisons the host.
The prevailing assumption in metabolic engineering attributes titre limits to pathway flux imbalances, leading programmes to focus on promoter tuning and enzyme homologue screening. Yet because every record-setting fermentation incorporates an organic overlay that continuously strips the volatile terpene, the aqueous cytotoxicity threshold has never been quantified under fed-batch conditions. Existing studies cannot separate stoichiometric exhaustion from product inhibition. Without measuring intracellular metabolite pools and off-gas carbon balances in an overlay-free system, researchers cannot determine whether intermediates accumulate behind an enzyme bottleneck or whether dissolved limonene compromises membrane integrity well short of the pathway's carbon-limited stoichiometric ceiling of 0.667 mol limonene per mol sucrose.
The Microbial Chemical Production Apodex Lab measures specific limonene productivity, cell viability, and pathway intermediate levels across controlled product concentrations in overlay-free fed-batch cultures on industrial cane sucrose at 25–40 g dry cell weight per litre. By quantifying carbon closure alongside intracellular pools of acetyl-CoA, mevalonate, and phosphorylated precursors at the half-maximal inhibition concentration, the protocol establishes the true cause of the production stall. The resulting data decide whether engineering effort must redirect toward in-situ product removal and membrane tolerance, or whether constructing further promoter libraries is justified to unblock a confirmed metabolic constraint.
WHY NOW
Why the field is spending on an assumption
Standard terpenoid fermentation relies on organic overlays to extract limonene and avoid toxicity, reaching published records of 7.3 g/L with an overlay against 3.6 g/L in aqueous broth. The overlay continuously strips the product, so existing high-titre runs obscure whether production stalls from pathway flux limits or limonene cytotoxicity. Operating without an overlay is necessary to determine whether aqueous titres above 5 g/L are biologically feasible on industrial sucrose. Comparing carbon-closed yields against stoichiometric ceilings and measuring intracellular mevalonate pathway intermediates now allows researchers to distinguish enzyme bottlenecks from product inhibition under fed-batch conditions.
WHAT WE’D BUY
What we would ask a laboratory to run
We are not buying the answer. We are buying a measurement with an interval — and the bars it will be compared against.
An engineered Escherichia coli strain producing (4S)-(−)-limonene and a pathway-null control are grown in overlay-free fed-batch cultures on industrial cane sucrose to 25–40 g dry cell weight per litre. Cultures receive controlled feeds of (4R)-(+)-limonene across four broth loadings. The measurement determines the carbon-closed molar yield on sucrose at the stall point as a percentage of the 0.667 mol/mol theoretical ceiling, reported with a 95% confidence interval half-width within 8 percentage points. Deliverables include the broth concentrations causing 10% and 50% productivity loss with 95% confidence intervals, flow-cytometric membrane integrity, and intracellular fold changes for acetyl-CoA, mevalonate, mevalonate-5-phosphate, and IPP and DMAPP, resolved to 1.8-fold pool changes.
SCOPE & LIMITS
The trial tests a single plasmid-borne Escherichia coli configuration under imposed external limonene exposure, so measured inhibition thresholds provide upper bounds on tolerance rather than direct design values for chromosomally integrated industrial strains.
WHO EXECUTES
The kind of lab that can run this
A fermentation-capable industrial biotechnology CRO or university bioprocess core with BSL-1/2 containment, instrumented 0.5–2 L fed-batch bioreactors or parallel microbioreactors, GC-MS/LC-MS metabolomics and cell-viability/flow-cytometry capability.
EXECUTOR KIND
wet-lab
WAYS IN
FOR PIs, LABS & CROs
Complete tasks no model can.
Paid per task, credited by name — a “Verified by” line for as long as the discovery it settled exists. You choose the work: browse the tasks above, respond to what you can actually run.
CREATE AN APODEX LAB
Have a question of your own?
Give it its own laboratory. Watch it decompose into an executable manifest.
ASK A FOLLOW-UP QUESTION
Push on our assumptions.
Every Apodex Lab lists what it doesn’t know. Good questions compound.
Every Apodex Lab shares the same verified-knowledge ledger. No laboratory works alone.